31
Participants
Start Date
October 31, 2005
Primary Completion Date
August 31, 2011
Study Completion Date
November 30, 2011
Capecitabine
825 mg/m2 bid (on each therapy day of first 4 therapy weeks)
Cetuximab
400mg/m2 week 1, 250mg/m2 week 2-4
Medical University of Vienna, Radiotherapy, Vienna
Hospital Wiener Neustadt, Surgery, Wiener Neustadt
Hospital BHS Linz, Radiooncology, Linz
Klinikum Wels-Grieskirchen, Wels
Paracelsus Medical University Salzburg - Oncology, Salzburg
Medical University of Innsbruck, Surgery, Innsbruck
State Hospital Feldkirch, Feldkirch
Medical University of Graz, Oncology, Graz
State Hospital Leoben, Leoben
Hospital BHB St. Veit/Glan, Surgery, Saint Veit A. D. Glan
Hoffmann-La Roche
INDUSTRY
Merck Gesellschaft mbH, Austria
INDUSTRY
Austrian Breast & Colorectal Cancer Study Group
NETWORK